A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer
{{output}}
Purpose/objective(s): To report results from our phase II study of stereotactic body radiotherapy (SBRT) delivering 36 Gy in 4 fractions for patients with localized prostate cancer. ... ...
